<VariationArchive VariationID="5972" VariationName="NM_020806.4(GPHN):c.65-?_201+?del" VariationType="Deletion" Accession="VCV000005972" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-05-12" DateCreated="2013-11-13" MostRecentSubmission="2024-05-12">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="21011" VariationID="5972">
      <GeneList>
        <Gene Symbol="GPHN" FullName="gephyrin" GeneID="10243" HGNC_ID="HGNC:15465" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>14q23.3-24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66508147" stop="67735355" display_start="66508147" display_stop="67735355" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" start="66974124" stop="67648524" display_start="66974124" display_stop="67648524" Strand="+" />
          </Location>
          <OMIM>603930</OMIM>
          <Haploinsufficiency last_evaluated="2022-06-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GPHN">Some evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2022-06-22" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GPHN">No evidence available</Triplosensitivity>
        </Gene>
        <Gene Symbol="LOC129390637" FullName="MPRA-validated peak2180 silencer" GeneID="129390637" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66714428" stop="66714628" display_start="66714428" display_stop="66714628" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130055881" FullName="ATAC-STARR-seq lymphoblastoid silent region 5854" GeneID="130055881" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66508732" stop="66508881" display_start="66508732" display_stop="66508881" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130055882" FullName="ATAC-STARR-seq lymphoblastoid active region 8568" GeneID="130055882" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66508972" stop="66509131" display_start="66508972" display_stop="66509131" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130055883" FullName="ATAC-STARR-seq lymphoblastoid active region 8569" GeneID="130055883" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66509382" stop="66509431" display_start="66509382" display_stop="66509431" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130055884" FullName="ATAC-STARR-seq lymphoblastoid active region 8570" GeneID="130055884" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66610202" stop="66610271" display_start="66610202" display_stop="66610271" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130055885" FullName="ATAC-STARR-seq lymphoblastoid active region 8571" GeneID="130055885" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66650551" stop="66650750" display_start="66650551" display_stop="66650750" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130055886" FullName="ATAC-STARR-seq lymphoblastoid active region 8572" GeneID="130055886" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66650761" stop="66650820" display_start="66650761" display_stop="66650820" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130055887" FullName="ATAC-STARR-seq lymphoblastoid active region 8573" GeneID="130055887" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66650871" stop="66650930" display_start="66650871" display_stop="66650930" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC130055888" FullName="ATAC-STARR-seq lymphoblastoid active region 8574" GeneID="130055888" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66651011" stop="66651100" display_start="66651011" display_stop="66651100" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132090246" FullName="Neanderthal introgressed variant-containing enhancer experimental_35661" GeneID="132090246" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66593029" stop="66593198" display_start="66593029" display_stop="66593198" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132090247" FullName="Neanderthal introgressed variant-containing enhancer experimental_35749" GeneID="132090247" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66689902" stop="66690071" display_start="66689902" display_stop="66690071" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132090248" FullName="Neanderthal introgressed variant-containing enhancer experimental_35767" GeneID="132090248" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66720122" stop="66720291" display_start="66720122" display_stop="66720291" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132090249" FullName="Neanderthal introgressed variant-containing enhancer experimental_35856" GeneID="132090249" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66809656" stop="66809825" display_start="66809656" display_stop="66809825" Strand="+" />
          </Location>
        </Gene>
        <Gene Symbol="LOC132090250" FullName="Neanderthal introgressed variant-containing enhancer experimental_35883" GeneID="132090250" Source="calculated" RelationshipType="genes overlapped by variant">
          <Location>
            <CytogeneticLocation>14q23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" start="66821614" stop="66821783" display_start="66821614" display_stop="66821783" Strand="+" />
          </Location>
        </Gene>
      </GeneList>
      <Name>NM_020806.4(GPHN):c.65-?_201+?del</Name>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>14q23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="14" Accession="NC_000014.9" outerStart="66508592" innerStart="66681106" innerStop="66776522" outerStop="66824473" display_start="66508592" display_stop="66824473" variantLength="95417" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="14" Accession="NC_000014.8" outerStart="66975310" innerStart="67147824" innerStop="67243240" outerStop="67291191" display_start="66975310" display_stop="67291191" variantLength="95417" />
      </Location>
      <OtherNameList>
        <Name>EX2-3DEL</Name>
      </OtherNameList>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008875.1" sequenceAccession="NG_008875" sequenceVersion="1" change="g.(6186_178700)_(274116_322067)del">
            <Expression>NG_008875.1:g.(6186_178700)_(274116_322067)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="protein">
          <ProteinExpression sequenceAccessionVersion="NP_065859.1" sequenceAccession="NP_065859" sequenceVersion="1" change="p.Val22Glyfs*8">
            <Expression>NP_065859.1:p.Val22Glyfs*8</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.8" sequenceAccession="NC_000014" sequenceVersion="8" change="g.(66975310_67147824)_(67243240_67291191)del" Assembly="GRCh37">
            <Expression>NC_000014.8:g.(66975310_67147824)_(67243240_67291191)del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000014.9" sequenceAccession="NC_000014" sequenceVersion="9" change="g.(66508592_66681106)_(66776522_66824473)del" Assembly="GRCh38">
            <Expression>NC_000014.9:g.(66508592_66681106)_(66776522_66824473)del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603930.0001" DB="OMIM" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">Deletion of exons 2 and 3 from gene GPHN with frameshift.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_020806.4(GPHN):c.65-?_201+?del AND Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C" Accession="RCV000006336" Version="4">
        <ClassifiedConditionList TraitSetID="1651">
          <ClassifiedCondition DB="MedGen" ID="C1854990">Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-01-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2001-01-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2013-11-13" MostRecentSubmission="2024-05-12">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11095995</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="1651" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="9040" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Molybdenum cofactor deficiency C</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C</ElementValue>
                <XRef ID="MONDO:0014212" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Molybdenum cofactor deficiency, complementation group C</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">MOCODC</ElementValue>
                <XRef Type="MIM" ID="615501" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Molybdenum cofactor deficiency (MoCD) represents a spectrum, with some individuals experiencing significant signs and symptoms in the neonatal period and early infancy (termed early-onset or severe MoCD) and others developing signs and symptoms in childhood or adulthood (termed late-onset or mild MoCD). Individuals with early-onset MoCD typically present in the first days of life with severe encephalopathy, including refractory seizures, opisthotonos, axial and appendicular hypotonia, feeding difficulties, and apnea. Head imaging may demonstrate loss of gray and white matter differentiation, gyral swelling, sulci injury (typically assessed by evaluating the depth of focal lesional injury within the sulci), diffusely elevated T2-weighted signal, and panlobar diffusion restriction throughout the forebrain and midbrain with relative sparring of the brain stem. Prognosis for early-onset MoCD is poor, with about 75% succumbing in infancy to secondary complications of their neurologic disability (i.e., pneumonia). Late-onset MoCD is typically characterized by milder symptoms, such as acute neurologic decompensation in the setting of infection. Episodes vary in nature but commonly consist of altered mental status, dystonia, choreoathetosis, ataxia, nystagmus, and fluctuating hypotonia and hypertonia. These features may improve after resolution of the inciting infection or progress in a gradual or stochastic manner over the lifetime. Brain imaging may be normal or may demonstrate T2-weighted hyperintense or cystic lesions in the globus pallidus, thinning of the corpus callosum, and cerebellar atrophy.</Attribute>
                <XRef ID="NBK575630" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17388" />
                <XRef ID="17388" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">34870926</ID>
                <ID Source="BookShelf">NBK575630</ID>
              </Citation>
              <XRef ID="308400" DB="Orphanet" />
              <XRef ID="833" DB="Orphanet" />
              <XRef ID="C1854990" DB="MedGen" />
              <XRef ID="MONDO:0014212" DB="MONDO" />
              <XRef Type="MIM" ID="615501" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="26518" SubmissionDate="2013-11-05" DateLastUpdated="2024-05-12" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603930.0001_MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C" title="GPHN, EX2-3DEL_MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C" />
        <ClinVarAccession Accession="SCV000026518" DateUpdated="2024-05-12" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-01-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Reiss et al. (2001) studied the last of 3 affected infants born to a Danish mother and father who were cousins. All 3 died in the neonatal period (at day 12, 29, and 3, respectively), with symptoms identical to those of molybdenum cofactor (MoCo) deficiency (MOCODC; 615501). Three other pregnancies of the mother resulted in 2 healthy sibs and 1 spontaneous abortion. The first affected infant was a boy; the other 2 were girls. All showed hypotonia combined with hyperreflexia, as well as tonic-clonic convulsions. Fibroblasts of the third infant were used to verify molybdenum cofactor deficiency by biochemical and in vitro complementation assays and to isolate DNA for genetic analysis. Reiss et al. (2001) identified a deletion of exons 2 and 3 of the GPHN gene, resulting in a frameshift after only 21 codons of normal coding sequence.</Attribute>
              <Citation>
                <ID Source="PubMed">11095995</ID>
              </Citation>
              <XRef DB="OMIM" ID="615501" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GPHN" />
          </GeneList>
          <Name>GPHN, EX2-3DEL</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">EX2-3DEL</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603930.0001" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="26518" TraitType="Disease" MappingType="Name" MappingValue="MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C" MappingRef="Preferred">
        <MedGen CUI="C1854990" Name="Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

